HALO vs. HIMS
Compare and contrast key facts about Halozyme Therapeutics, Inc. (HALO) and Hims & Hers Health, Inc. (HIMS).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: HALO or HIMS.
Correlation
The correlation between HALO and HIMS is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
HALO vs. HIMS - Performance Comparison
Key characteristics
HALO:
1.23
HIMS:
2.37
HALO:
1.77
HIMS:
2.71
HALO:
1.28
HIMS:
1.38
HALO:
1.33
HIMS:
4.37
HALO:
3.82
HIMS:
11.39
HALO:
12.70%
HIMS:
20.70%
HALO:
39.49%
HIMS:
99.63%
HALO:
-74.26%
HIMS:
-87.29%
HALO:
-8.18%
HIMS:
-34.41%
Fundamentals
HALO:
$7.11B
HIMS:
$9.18B
HALO:
$3.43
HIMS:
$0.53
HALO:
16.82
HIMS:
78.00
HALO:
-2.50
HIMS:
3.96
HALO:
$1.02B
HIMS:
$1.48B
HALO:
$820.38M
HIMS:
$1.13B
HALO:
$646.55M
HIMS:
$72.93M
Returns By Period
In the year-to-date period, HALO achieves a 23.72% return, which is significantly lower than HIMS's 86.48% return.
HALO
23.72%
4.84%
-7.36%
43.88%
23.63%
14.23%
HIMS
86.48%
32.77%
206.11%
243.67%
35.47%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
HALO vs. HIMS — Risk-Adjusted Performance Rank
HALO
HIMS
HALO vs. HIMS - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Halozyme Therapeutics, Inc. (HALO) and Hims & Hers Health, Inc. (HIMS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
HALO vs. HIMS - Dividend Comparison
Neither HALO nor HIMS has paid dividends to shareholders.
Drawdowns
HALO vs. HIMS - Drawdown Comparison
The maximum HALO drawdown since its inception was -74.26%, smaller than the maximum HIMS drawdown of -87.29%. Use the drawdown chart below to compare losses from any high point for HALO and HIMS. For additional features, visit the drawdowns tool.
Volatility
HALO vs. HIMS - Volatility Comparison
The current volatility for Halozyme Therapeutics, Inc. (HALO) is 4.40%, while Hims & Hers Health, Inc. (HIMS) has a volatility of 54.10%. This indicates that HALO experiences smaller price fluctuations and is considered to be less risky than HIMS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
HALO vs. HIMS - Financials Comparison
This section allows you to compare key financial metrics between Halozyme Therapeutics, Inc. and Hims & Hers Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities